At Kelley Kronenberg, we do not measure our success by comparison, but by our own standard. The strength of our relationships defines who we are. We realize that the legal landscape has changed, and we are leading the way with innovation and a cutting edge business model.
In these times, when many firms have struggled or have been forced to scale back, Kelley Kronenberg has experienced record growth. Our dedication to our clients has made the difference. We understand that over the years, the needs and expectations of clients has changed. We strive to keep ahead of this change with a relentless focus on emerging trends. Most importantly, we tirelessly seek out new ways to add value by understanding our clientsÕ business needs and ambitions.
We are proud of the strength and longevity of our employee relationships, with numerous employees boasting more than twenty years of service with the firm. This serves as an inspiration and a goal for all of our employees, bringing about superlative levels of commitment, enthusiasm and performance.
Our durable employee relationships characterize the partners and the firm and thereby serve as the foundation for our ongoing ability to establish, broaden and sustain client relationships. With mutual trust and admiration at the core of our client relationships, we have enjoyed the loyalty of many of our clients for more than thirty years.
As we continue to lead our industry in innovation, our dedication to our clients and employees stands primary because we know that the collective strength of our individual relationships is what allows us to stand with you as we represent you.
Kelley Kronenberg maintains 10 offices - 9 locations throughout the state of Florida, as well as an office in Chicago.
- Company Name:Kelley Kronenberg
(View Trends)
-
Headquarters: (View Map)Fort Lauderdale, FL, United States
-
Law Practice
-
200 - 500 employees
- 2376743 Global Rank
- 465013 United States
-
Search53.33%
-
Direct43.51%
-
Social3.15%
-
Display0.00%
-
Mail0.00%
-
Referrals0.00%
- United Kingdom 88.9%
- United States 2.5%
- India 1.1%
- Netherlands 1.0%
- Italy 0.2%
- Biotechnology and Pharmaceuticals
- Pharmaceuticals